e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Azithromycin, a novel maintenance therapy in patients with chronic non-CF suppurative lung disease
S. Twite, P. Stockton, S. Agarwal (Liverpool, United Kingdom)
Source:
Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Session:
Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Session type:
Thematic Poster Session
Number:
2544
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Twite, P. Stockton, S. Agarwal (Liverpool, United Kingdom). Azithromycin, a novel maintenance therapy in patients with chronic non-CF suppurative lung disease. Eur Respir J 2011; 38: Suppl. 55, 2544
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Azithromycin in the treatment of children with chronic inflammatory lung disease (CILD)
Source: Eur Respir J 2004; 24: Suppl. 48, 391s
Year: 2004
The association of bronchial colonization with the extent of lung lesions in children with non-CF chronic suppurative lung disease or recurrent pneumonia
Source: Annual Congress 2009 - Fiberoptic bronchoscopy in the diagnosis of respiratory diseases in children
Year: 2009
Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
Immunomodulative therapy in young patients with non-CF bronchiectases exacerbations
Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood
Year: 2009
What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009
Compliance with nebulized therapy in patients with chronic lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 59s
Year: 2001
Antibiotic treatment and prophylaxis
Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases
Year: 2006
Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 138s
Year: 2001
Is infection screening in BAL fluid useful in children with chronic obstructive airway disease unresponsive to anti-asthmatic treatment?
Source: Eur Respir J 2006; 28: Suppl. 50, 310s
Year: 2006
A level of an alpha-1-proteinihibitor in patients with chronic bronchitis and lung tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 339s
Year: 2003
The impact of COVID-19 on children with chronic suppurative lung disease
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021
Prevention and treatment of exacerbations of non-CF bronchiectasis
Source: Eur Respir Monogr 2013; 60: 127-136
Year: 2013
Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007
Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
Azithromycin in the treatment of children with chronic airway disease (CAD)
Source: Eur Respir J 2003; 22: Suppl. 45, 143s
Year: 2003
Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005
Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020
The role of pulmonary rehabilitation in the prevention of exacerbations of chronic lung diseases
Source: Eur Respir Monogr 2017; 77: 224-246
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept